Found: 13
Select item for more details and to access through your institution.
Volunteer Challenge With Enterotoxigenic Escherichia coli That Express Intestinal Colonization Factor Fimbriae CS17 and CS19.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 1, p. 60, doi. 10.1093/infdis/jir220
- By:
- Publication type:
- Article
Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 4, p. 1, doi. 10.1371/journal.pntd.0006442
- By:
- Publication type:
- Article
Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701).
- Published in:
- Microorganisms, 2024, v. 12, n. 4, p. 727, doi. 10.3390/microorganisms12040727
- By:
- Publication type:
- Article
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers
- Published in:
- Microorganisms, 2024, v. 12, n. 2, p. 288, doi. 10.3390/microorganisms12020288
- By:
- Publication type:
- Article
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 9, p. 1435, doi. 10.1093/cid/cix1014
- By:
- Publication type:
- Article
An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149358
- By:
- Publication type:
- Article
Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection.
- Published in:
- NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0131-7
- By:
- Publication type:
- Article
Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194325
- By:
- Publication type:
- Article